RESEARCHER PROFILE

Mark Hatherill

← Back to Institute of Infectious Disease and Molecular Medicine

M

Institute of Infectious Disease and Molecular Medicine

Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisImmune responses and vaccinationsDiagnosis and treatment of tuberculosisSepsis Diagnosis and Treatment

Mark Hatherill works in Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, Immune responses and vaccinations, Diagnosis and treatment of tuberculosis, Sepsis Diagnosis and Treatment. Recorded institutional associations include University of Cape Town, South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine.

417Publications
17,386Citations
70H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

    2013 · 1,049 citations
  2. A blood RNA signature for tuberculosis disease risk: a prospective cohort study

    2016 · 780 citations
  3. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

    2018 · 652 citations
  4. Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis

    2019 · 595 citations
  5. High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

    2014 · 432 citations
  6. Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis

    2018 · 413 citations
  7. Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns

    2010 · 402 citations
  8. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

    2020 · 349 citations
  9. Evaluation of Tuberculosis Diagnostics in Children: 1. Proposed Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease. Consensus From an Expert Panel

    2012 · 325 citations
  10. T-cell activation is an immune correlate of risk in BCG vaccinated infants

    2016 · 267 citations
  11. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count

    1999 · 261 citations
  12. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease

    2017 · 251 citations
  13. Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis

    2018 · 251 citations
  14. The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults

    2010 · 227 citations
  15. Clinicians' abilities to estimate cardiac index in ventilated children and infants

    1997 · 224 citations
  16. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

    2015 · 198 citations
  17. Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

    2009 · 190 citations
  18. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis

    2016 · 186 citations
  19. The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children

    2011 · 183 citations
  20. Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis

    2017 · 179 citations
  21. Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock

    2000 · 178 citations
  22. Clinical validation of cardiac output measurements using femoral artery thermodilution with direct Fick in ventilated children and infants

    1997 · 178 citations
  23. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

    2020 · 177 citations
  24. Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa

    2008 · 173 citations
  25. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise

    2024 · 171 citations

← Return to the university profile